|Montreal, 14 May 2020
Annually, the World Anti-Doping Agency (WADA) consults its stakeholders to review the content and structural changes being proposed to the following year’s List of Prohibited Substances and Methods (Prohibited List), which is an International Standard under Article 4.1 of the World Anti-Doping Code (Code).
As part of the consultation process, stakeholder feedback is collected throughout the year. Then, in April of every year, WADA’s List Expert Group meets to discuss the feedback, evidence and proposed content and/or structural changes; and, to formulate the draft Prohibited List for the following year.
On 23, 24 and 27 April, the List Expert Group met virtually. This resulted in the following documents, which we are confidentially giving you access to today for Stakeholder Consultation purposes via WADAConnect, the Agency’s online stakeholder consultation platform:
As is customary, WADA kindly asks that someone within your organization, with the relevant professional experience and expertise in anti-doping, be given the opportunity to carefully review the draft 2021 Prohibited List and provide comments concerning the proposed content (additions, deletions or other modifications) and/or structural changes. We would ask that, whenever possible, comments be supported by relevant reference(s) to medical or scientific evidence; pharmacological effect; and/or, personal experience concerning the substances or methods in question.
- Draft 2021 Prohibited List
- Draft 2021 Monitoring Program
- Summary of Major Modifications and Explanatory Notes, which are intended to facilitate your review
As usual, the WADAConnect platform will encourage respondents, separately, to propose further additions, deletions or other modifications under ‘Comments for future consideration’; which, will be evaluated and considered carefully over the course of the year but are unlikely to be incorporated within the 2021 Prohibited List.
We believe that conducting this Stakeholder Consultation helps ensure that the Prohibited List evolves in step with the highest possible scientific standards; and, reflects the needs of the anti-doping community.
In keeping with the annual process, the 2021 Prohibited List will not be made public until after it is approved by WADA’s Executive Committee at its September meeting. Therefore, we ask you to ensure that the draft is kept confidential in order to preserve the integrity of the Stakeholder Consultation process. As we know, earlier publication would compromise the process and lead to confusion in the minds of athletes and other stakeholders worldwide.
To provide comments
Should you have any questions or concerns, please contact email@example.com.
- Simply connect to WADAConnect. If you do not currently have access, please consult the short guide on how to create a user account that is available on the platform.
- Once you have a user account, please inform Ms. Hai-Yen Huynh at WADA’s Science & Medical Department at firstname.lastname@example.org and ask to be added to the private List Consultation Group. This is necessary in order to provide comments.
- Please input your comments by 12 July 2020.
Thank you in advance for your organization’s feedback.
World Anti-Doping Agency